Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA. 2003 Dec 17; 290(23):3073-80.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
CD11 Antigens
Dermatologic Agents
Double-Blind Method
Female
Humans
Male
Middle Aged
Psoriasis
Quality of Life
Severity of Illness Index
T-Lymphocytes
Treatment Outcome
authors with profiles
Kenneth Gordon